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ABSTRACT
Purpose: This study aimed to evaluate the quality of life (QOL) and verify the domains of greater impact in
patients with focal and generalized epilepsies. Methods: The sample, composed by 57 subjects from Hospital
São Paulo da Universidade Federal de São Paulo, was divided into 3 groups, temporal lobe epilepsies (TLE),
extra-temporal epilepsies (Extra-TLE) and idiopathic generalized epilepsy (IGE). They answered a preliminary
self-reported questionnaire to identify the perception of the most impaired aspects in their lives. The QOL
was evaluated through the validated Brazilian version of the Quality of Life Epilepsy Inventory 31 (QOLIE-31).
The correlation of the QOLIE-31 domains with epilepsy duration and seizure frequency was defined by
dispersion graphics and also Pearson’s and Spearman’s correlation. Results: The most frequently identified
impact of epilepsy was related to interpersonal, familial and social relationships mentioned by 13 (22.81%)
patients. The seizure frequency per patient in Extra-TLE group was significantly greater (p = 0.007) than
in the other groups. The Cognition Functioning scores were lower for the Extra-TLE group (38.4) when
compared with TLE (52.6) and IGE (62.6) (p = 0.01). The correlation between epilepsy duration and
QOLIE-31 domains did not demonstrate statistical significance; however, seizure frequency was correlated
with Seizures Worry (p = 0.0463, α = 0.05) and Medication Effects (p = 0.0476, α = 0.05) domains.
Conclusions: 1) Interpersonal, familial, and social relationships were the dimension which most impacted
daily life; 2) Cognition domain in Extra-TLE group showed the worst scores; 3) QOL scores were similar in
the three groups for the majority of the QOLIE-31 domains; 4) The seizure frequency in the Extra-TLE
group was significantly greater; 5) Seizure frequency was associated with worse QOLIE-31 scores in the
domains Seizure Worry and Medication Effects.
Key words: quality of life (QOL), QOLIE-31, temporal lobe epilepsy (TLE), extra-temporal lobe epilepsy
(extra-TLE), idiophatic generalized epilepsy (IGE), self-perception of epilepsy impact.
RESUMO
Qualidade de vida e percepção sobre impacto em três diferentes tipos de epilepsias
Objetivo: Este estudo teve como objetivo avaliar a qualidade de vida (QV) em três diferentes grupos de
epilepsia e verificar a esfera percebida como de maior impacto na vida diária. Metodologia: A amostra foi
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INTRODUCTION
Focal epilepsies present higher prevalence than idio-
pathic generalized epilepsies (IGE). Among focal epi-
lepsies, mesial temporal lobe epilepsy (TLE) is the epileptic
syndrome more frequently diagnosed in adults, ranging
between 50 and 75%. From these, 30-40% will not obtain
control of the seizures despite appropriate treatment.12
Because of its lower response to antiepileptic drugs
(AEDs), TLE represents 70% to 85% of the epilepsy
surgeries.22
Of all epilepsy types, IGE range from 15.7% to 34.5%.
Among them, juvenile myoclonic epilepsy (JME) is the
most common type, corresponding to 20% to 27%. Eighty
per cent of these patients reach seizure control with
valproate, considered a first line drug for the treatment of
this syndrome.4,13,18
Epilepsy carries a substantial burden of illness, re-
flected in poorer quality of life (QOL) and psychosocial
function.25 The influence of epilepsy on patient’s lives may
be quite destructive, with many complains of restrictive
daily activities and impaired QOL.6 Persons with epilepsy
often feel stigmatized by their condition. Emotional
distress, social isolation and withdrawal, reduced self-
esteem, unemployment or underemployment, are also
linked to epilepsy.1,6
The frequency and seizure severity, adverse effects
of AEDs, seizure worry, mood status, physical, cognitive
and psychosocial limitations, including dependence of
caregivers, are determinant aspects frequently assessed by
QOL inventories. On the other hand, satisfactory seizure
control by AEDs and eligibility to surgical treatment are
favorable aspects to the improvement of QOL.24
The Quality of Life in Epilepsy Inventory 31 – QOLIE-
317 has been the most frequently used instrument world-
wide because of its concise and easy evaluation.
The aim of this study was to evaluate the QOL using
the Brazilian version of the QOLIE-318 in three different
epilepsy groups: TLE, Extra-TLE and JME and identify in
the total sample the most important areas of epilepsy daily
impact.
METHODS
The sample was composed by 57 outpatients from
Hospital São Paulo da Universidade Federal de São Paulo and
the data were collected between June and August of 2007.
The patients signed a consenting form for a voluntary
participation in the study. Patients with neoplasias,
psychiatric disturbances and those in post-surgical follow-
up or illiterate were excluded of this study.
In a semi structured interview, the clinical data
(seizure frequency, duration of epilepsy, medications in use
and adverse effects of AEDs) and demographic status (age,
sex, schooling, and occupation) were obtained. The data was
obtained during the interview as well as in the medical visits.
Subjects were asked to identify in an interview, the
three most affected dimensions in their lives in decreasing
order of importance. They could choose among the
following dimensions: emotional problems; interpersonal,
familial and social relationships; work difficulties; treat-
ment and AEDs problems like costs, adverse effects and
toxicity; self-sufficiency, co-dependence or dependence;
fear of hurting him/herself during a seizure; memory,
reasoning and other cognitive impairments. The QOL was
evaluated in the same interview through the Brazilian
composta por 57 pacientes com epilepsias focais e generalizadas do Hospital São Paulo, Universidade Fe-
deral de São Paulo, divididos em três grupos, epilepsias do lobo temporal (ELT), extratemporais (Extra-ELT)
e generalizadas idiopáticas (EGI). Os pacientes responderam a um questionário preliminar para identificar a
percepção sobre os aspectos mais comprometidos em suas vidas. A QV foi avaliada por meio da versão
brasileira do Quality of Life in Epilepsy Inventory 31 (QOLIE-31). A correlação dos domínios do QOLIE-31
com a duração da epilepsia e freqüência de crises foi definida pela inspeção dos gráficos de dispersão e pela
correlação de Pearson e de Spearman. Foram considerados significantes os valores de p < 0,05. Resulta-
dos: Dificuldades nas relações interpessoais, familiares e sociais foram apontadas como a esfera de maior
impacto relacionado à epilepsia, citada por 13 (22,81%) pacientes. O QOLIE-31 mostrou resultado seme-
lhante nos três diferentes tipos de epilepsia, com exceção do domínio Funcionamento Cognitivo. Os escores
deste domínio foram significativamente menores (p = 0,01) no grupo com Extra-ELT (38,4) do que nos
grupos ELT (52,6) e EGI (62,6). A duração da epilepsia não influenciou na QOL nesta amostra, porém foi
observada uma correlação estatística significante entre a freqüência de crises e os domínios Efeitos da Medi-
cação (p = 0,0476, α = 0,05) e Preocupação com Crises (p = 0,0463, α = 0,05). A freqüência de crises
mostrou ainda uma diferença estatisticamente significante (p = 0.007) no grupo com Extra-ELT, que apre-
sentou mais crises/paciente, quando comparado aos demais grupos. Conclusões: Os pacientes identificaram
as relações interpessoais, familiares e sociais como sendo a área mais afetada pela epilepsia. O domínio
Funcionamento Cognitivo mostrou-se como fator determinante na QOL do grupo Extra-ELT. A freqüência de
crises influenciou a QOL nos domínios Preocupação com Crises e Efeitos da Medicação nos três grupos.
Unitermos: qualidade de vida (QV), QOLIE-31, epilepsia do lobo temporal (ELT), epilepsia extratemporal
(extra-ELT), epilepsia generalizada idiopática (EGI), percepção sobre o impacto da epilepsia.
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version of the QOLIE-31, after the application of the
preliminary self-reported questionnaire.
The QOLIE-31 is composed by 30 items organized into
seven subscales: Seizure Worry (5 items), Overall Quality
of Life (2 items), Emotional Well-being (5 items), Energy-
Fatigue (4 items), Cognitive Function (6 items), Medication
Effects (3 items) and Social Function (5 items). The raw
scores are rescaled from zero to 100 with higher values
reflecting better QOL.
STATISTICAL ANALYSIS
The correlation between the QOLIE-31 domains with
epilepsy duration and seizure frequency was defined by
dispersion graphics and also by Pearson and Spearman
correlation.
The data distribution in the continuous variables was
verified by Shapiro-Wilk test, quartile graphs and quartile
interval (25th and 75th percentile). The normal data distri-
bution was expressed by means and standard deviation.
The categorical variables were described by fre-
quencies and percentages of each factor level.
The one-way ANOVA defined the significance of the
difference among the three epilepsy types in the different
QOLIE-31 domains, and the variable monthly seizure
frequency was analyzed by the Kruskal-Wallis and Mann-
Whitney test with correction of the significance level given
by Bonferroni. For all tests p values < 0.05 were considered
statistically significant.
We hypothesized a statistical difference between QOL
in JME (IGE) group and focal epilepsies groups (TLE and
Extra-TLE), with better scores for the JME group.
RESULTS
This series assessed 57 subjects, 27 (47.4%) male, mean
age 33.44 (10.51) yrs. (range, 14-56 yrs). Schooling was
classified in four groups: 1 to 4 years of education, n = 9
(15.8%); 5 to 8, n = 14 (24.6%); 9 to 11, n = 24 (42.1%),
and more than 11 years of education, n = 10 (17.5%). As
employemt status, 17 (29.8%) patients were employed full-
time, 12 (21.0%) were autonomous and 11 (19.3%) were
unemployed. The data are summarized in Table 1.
Of the 57 patients, 39 had focal epilepsies and 18 IGE.
In the focal epilepsies group 27 (47.4%) were diagnosed
as TLE and 12 (21%) as Extra-TLE, while in the IGE group
all the 18 (31.6%) had JME.
The age of the first seizure ranged from 1 to 38 years
of age, mean 13.5 (9.29) and the mean epilepsy duration
was 20.2 (10.47) years (Graphic 1).
The seizure frequency of the different samples was 188
seizures in 27 subjects in TLE group; 133.3 seizures in 12
patients in Extra-TLE group and 30.8 seizures in 18 JME
(IGE) subjects. TLE seizure frequency (total number
seizures) monthly was 4.0 [1.0; 8.5], Extra-TLE, 3.5 [2.3;
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Seizure frequency
per month in the
three epilepsy
groups.
Table 1. Sociodemographic aspects.
Characteristics Frequency (%) 
Gender 
Female n = 30 (52.6%) 
Male n = 27 (47.4%) 
Schooling 
≤ 4 years of education n =   9 (15.8%) 
≤ 8 years of education n = 14 (24.6%) 
≤ 11 years of education n = 24 (42.1%) 
Higher education n = 10 (17.5%) 
Employment situation 
Employed n = 17 (29.8%) 
Autonomous n = 12 (21.0%) 
Retired due to ill-health/ 
Government support for illness n =   7 (12.3%) 
Unemployed or jobless n = 11 (19.3%) 
Student and housewife n = 10 (17.5%) 
10.5] and JME (IGE), 1.0 [0.0; 3.5]. Seizure frequency per
patient was greater in the Extra-TLE group (Graphic 2).
There was a statistical significant difference in seizure
frequency per patient (p = 0.007) only when Extra-TLE
and JME (IGE) groups were compared.
Graphic 1. Age and epilepsy duration-mean (years).
Age Epilepsy duration in years
Quality of life and the self-perception impact ...
194
In this study, the most frequently identified impact of
epilepsy was related to interpersonal, familial and social
relationships expressed by problematic family interactions,
difficulties in making friends, feelings of isolation and
withdrawal, stigmatization, embarrassment resulting from
having a seizure in public, inability to start a conversation
in a social group mentioned by 13 (22.81%) patients.
Problems with AEDs were reported by 10 (17.54%) as
costs of the drugs, regular time to take the medications,
adverse effects as sleepiness, shaky hands, tiredness, loss
of energy, fatigue, worry about adverse effects of AEDs if
taken for a long time, dependence of the medicines,
limitations for leisure time or recreation activities.
Emotional problems as depression, mood swings,
sadness, anxiety, fear, irritability, shyness and feelings of
failure in life were reported by 9 (15.79%) subjects and
work difficulties by 9 (15.79%) expressed in worry about
losing the job, unemployment, employment restrictions,
limited performing and inability to attain more responsible
job as seen in Table 2.
Table 2. Seizure impact* in daily life.
Impact Dimensions Number = 57 % 
Emotional problems 9 15.79 
Interpersonal, familial and social 
relationships 13 22.81 
Work difficulties 9 15.79 
Treatment and antiepileptic drugs 
problems 10 17.54 
Self-sufficiency, co-dependence or 
dependence 5 8.77 
Fear from hurting him/herself 5 8.77 
Cognitive impairments 6 10.53 
* Self-perception questionnaire.
The results of QOL assessment obtained through
QOLIE-31 were compared among the three groups. The
analysis revealed a difference in Cognition for Extra-TLE
when compared with JME (IGE) group (p = 0.01). The
Extra-TLE group showed lower scores, indicating the
greatest impact in the Cognition domain of QOLIE-31.
The QOLIE-31 mean scores were outlined in Table 3.
Table 3. Results of QOLIE-31 domains in the three groups.
QOLIE-31 domains TLE Extra-TLE JME (IGE) 
Seizure worry ** 53.9 (31.1) 50.9 (33.9) 49.7 (28.0) 
Emotional well-being 60.6 (16.8) 60.7 (26.7) 63.5 (16.5) 
Energy/Fatigue 60.7 (18.1) 58.8 (18.6) 64.4 (17.0) 
Social Function 61.1 (24.1) 63.7 (15.0) 73.4 (21.8) 
Cognition 52.6 (23.4) 38.4 (28.4)* 62.6 (18.2) 
Medication side-effects ** 45.4 (28.6) 29.8 (25.4) 54.3 (31.7) 
Overall QOL 62.2 (17.3) 62.6 (22.6) 65.9 (15.6) 
The correlation between epilepsy duration and
QOLIE-31 domains was expressed in median (25th and 75th
percentile); Seizure worry 0.07 [-0.20; 0.34], Emotional
Well-being -0.15 [-0.41; 0.12], Energy/Fatigue -0.11 [-0.36;
0.17], Social Function -0.20 [-0.45; 0.07], Cognition -0.02
[-0.29; 0.25], Medication side-effects 0.06 [-0.21; 0.32], and
Overall QOL -0.04 [-0.30; 0.23]. These results did not
demonstrate statistically significant correlations between
QOLIE-31 domains.
We found a statistical association between the variable
seizure frequency and the QOLIE-31 domains’ Seizure
Worry (p = 0.046) and Medication Effects (p = 0.047).
DISCUSSION
The dimensions related to interpersonal, familial and
social relationships (22.81%), difficulties with the treat-
ment and medication (17.54%) and emotional problems
(15.79%) were mentioned in the interview, with a
substantial impact in daily life. Not surprisingly, the
patients in our focal group with medically intractable
epilepsy had multiple social and psychological disabilities.
They described difficulties in social situations, such as
schooling and interruption of familial relations.21 Other
investigations have also found that patients perceive
intractable epilepsy as having a devastating effect on the
work, social activities and performance in school.9 In Brazil
the situation is even more dramatic due to the burden of
treatment costs (medical visits, expenses with AEDs).
In this series only 17 (29.81%) patients were full-time
employed and difficulties with work dimension was
mentioned by 9 (15.79%) in the interview. The pro-
blematic employment situation for people with epilepsy is
well established. Unemployment rate experience by them
has frequently been shown to be higher than of general
population.11 It has been suggested that, with respect to
unemployment, the type, severity, and frequency of
seizures may be relevant.  Rates of unemployment have
consistently been found to be higher among individuals
with more frequent seizures.5,16,26 Finally, fear of employer
and discrimination or stigmatization at work appears to
significantly influence the employment situation.3
The association of QOLIE-31 domains with epilepsy
syndromes showed a statistically significance only in the
Cognition Domain. The Extra-TLE group results were lower
as compared with JME scores. The Cognitive Domain of
the QOLIE-31 consists of questions concerning memory,
concentration, and reasoning. It was expected lower scores
in Cognition for the Extra TLE, in the view of the severity
of this type of epilepsy. The type and anatomic location of
brain pathology have crucial impact on cognitive deficit.23
Self-reported memory has been considered as im-
portant predictor of QOL, and therefore, correlates with
** Difference statistically significant (P = 0.01) compared with JME (IGE) group.
** (P = 0.05) in correlation with seizure frequency.
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performance on memory tests, suggesting that memory
improvement by specific training may help to improve
QOL.15,20
Significant relationships have been found between
memory complaints on the questionnaire and objective
performance in some neuropsychological tasks.17 Chronic
illness and emotional functioning were strongly related to
memory self-perceptions. Other studies also suggested that
patients’ characteristics may mediate the relationships
between subjective and objective memory as mentioned
by Helmstaedter and Elger17 who found that patients
with good memory abilities on neuropsychological tests
provided more accurate rating of their memory than did
patients with poorer memory abilities.
In this series demographic variables, such as duration
of epilepsy was not associated with QOLIE-31 scores,
maybe because most of the subjects had epilepsy for a long
time (mean = 20.2 years). In a Georgian study,10 the
variables that most strongly predicted a lower QOL sores
were lower educational level, higher seizure frequency, and
long duration of epilepsy.
In this study, we defined the statistical treatment of
the seizures frequency through median and quartile
interval (25th and 75th percentile) due to irregularity in the
data distribution of these variables. Mean and standard
deviation were applied in variables with regular parameters
in the data distribution. The use of median and quartiles
allowed larger robustness and accuracy for interpretation
of those data.
The association with seizure frequency and the
QOLIE-31 was higher for the domains Seizure Worry and
Medication Effects. The Seizure Worry domain consists of
items such as worry about future seizures, apprehension
over future injury resulting from seizures, trepidation
over adverse effects of medication regimens, and social
embarrassment over having seizures. In the original paper
of the QOLIE-31,7 patients with higher seizures frequency
scored significantly worse than patients whose seizures
were controlled and those with mild seizure frequency.
Frequent seizures have been found to be negatively
associated with QOL scores, and seizure-free patients have
been observed to have a health-related QOL similar to
that of general population.2,19
The Medication Effects domain of QOLIE-31 has three
questions about the medication worry if it is taken for a
long time, and the physical and mental possible adverse
events. It has been suggested that adverse events are
actually a great determinant of QOL.14 Most of the
important toxicity experienced by patients taking AEDs
may be sub-clinical and may not reach the attention of
the physician. Improvement in medication toxicity was
associated with improvement in QOL.14 Identifying
adverse medication effects in outpatients could lead a
better compliance, less AEDs events, and increase the
confidence in patient-medical relationship.
These results were limited in exploring the dimensions
and variables that may be of crucial impact in QOL.
Further investigation will be necessary to understand the
complex relationships with different epileptic syndromes
and its influence in patients QOL.
CONCLUSION
Overall, the results of this survey concluded: 1) Inter-
personal, familial, and social relationships were the
dimension which most impact in daily life; 2) Cognition
domain in Extra-TLE group showed the worst scores;
3) QOL scores were similar in the three groups for the
majority of the QOLIE-31 domains; 4) Seizure frequency
in the Extra-TLE group was significantly greater; 5) Seizure
frequency was associated with worse QOLIE-31 scores in
the domains Seizure Worry and Medication Effects.
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